Chlorobiphenyl
Latest Information Update: 14 Mar 2000
At a glance
- Originator Nonindustrial source
- Class Antithrombotics
- Mechanism of Action Cyclooxygenase inhibitors; Thromboxane receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 14 Mar 2000 No-Development-Reported for Thrombosis in Taiwan (Unknown route)
- 20 Feb 1997 New profile
- 20 Feb 1997 Preclinical development for Thrombosis in Taiwan (Unknown route)